173 related articles for article (PubMed ID: 31557077)
21. Normocalcemic Primary Hyperparathyroidism in Adults Without a History of Nephrolithiasis or Fractures: A Prospective Study.
Rosário PW; Calsolari MR
Horm Metab Res; 2019 Apr; 51(4):243-247. PubMed ID: 30840998
[TBL] [Abstract][Full Text] [Related]
22. Vitamin D deficiency, parathyroid hormone levels, and bone disease among patients with end-stage liver disease and normal serum creatinine awaiting liver transplantation.
Corey RL; Whitaker MD; Crowell MD; Keddis MT; Aqel B; Balan V; Byrne T; Carey E; Douglas DD; Harrison ME; Vargas HE; Rakela J
Clin Transplant; 2014 May; 28(5):579-84. PubMed ID: 24628047
[TBL] [Abstract][Full Text] [Related]
23. Evaluation of coronary calcium score in patients with normocalcemic primary hyperparathyroidism.
Mesquita PN; Dornelas Leão Leite AP; Chagas Crisóstomo SD; Veras Filho E; da Cunha Xavier L; Bandeira F
Vasc Health Risk Manag; 2017; 13():225-229. PubMed ID: 28790836
[TBL] [Abstract][Full Text] [Related]
24. Normocalcemic primary hyperparathyroidism: a survey in a small village of Southern Italy.
Vignali E; Cetani F; Chiavistelli S; Meola A; Saponaro F; Centoni R; Cianferotti L; Marcocci C
Endocr Connect; 2015 Sep; 4(3):172-8. PubMed ID: 26155986
[TBL] [Abstract][Full Text] [Related]
25. Rationale for Raising Current Clinical Practice Guideline Target for Serum 25-Hydroxyvitamin D in Chronic Kidney Disease.
Strugnell SA; Sprague SM; Ashfaq A; Petkovich M; Bishop CW
Am J Nephrol; 2019; 49(4):284-293. PubMed ID: 30878999
[TBL] [Abstract][Full Text] [Related]
26. Serum 25-hydroxyvitamin D, parathyroid hormone, calcium intake, and bone mineral density in Spanish adults.
Olmos JM; Hernández JL; García-Velasco P; Martínez J; Llorca J; González-Macías J
Osteoporos Int; 2016 Jan; 27(1):105-13. PubMed ID: 26134682
[TBL] [Abstract][Full Text] [Related]
27. Normocalcaemic primary hyperparathyroidism: is nephrolithiasis more common than osteoporosis?
Wu KCJ; Anpalahan M
Intern Med J; 2023 Jan; 53(1):112-118. PubMed ID: 34435736
[TBL] [Abstract][Full Text] [Related]
28. Temporal relationship between vitamin D status and parathyroid hormone in the United States.
Kroll MH; Bi C; Garber CC; Kaufman HW; Liu D; Caston-Balderrama A; Zhang K; Clarke N; Xie M; Reitz RE; Suffin SC; Holick MF
PLoS One; 2015; 10(3):e0118108. PubMed ID: 25738588
[TBL] [Abstract][Full Text] [Related]
29. A new, vitamin D-based, multidimensional nomogram for the diagnosis of primary hyperparathyroidism.
Harvey A; Hu M; Gupta M; Butler R; Mitchell J; Berber E; Siperstein A; Milas M
Endocr Pract; 2012; 18(2):124-31. PubMed ID: 22068245
[TBL] [Abstract][Full Text] [Related]
30. Parathyroidectomy for Normocalcemic Primary Hyperparathyroidism is Associated with Improved Bone Mineral Density Regardless of Postoperative Parathyroid Hormone Levels.
Lui MS; Clemente-Gutierrez U; Vodopivec DM; Chang SL; Shirali AS; Huang BL; Chiang YJ; Fisher SB; Grubbs EG; Guise TA; Graham PH; Perrier ND
World J Surg; 2023 Feb; 47(2):363-370. PubMed ID: 36195677
[TBL] [Abstract][Full Text] [Related]
31. Association of low 25-hydroxyvitamin D concentrations with elevated parathyroid hormone concentrations and low cortical bone density in early pubertal and prepubertal Finnish girls.
Cheng S; Tylavsky F; Kröger H; Kärkkäinen M; Lyytikäinen A; Koistinen A; Mahonen A; Alen M; Halleen J; Väänänen K; Lamberg-Allardt C
Am J Clin Nutr; 2003 Sep; 78(3):485-92. PubMed ID: 12936933
[TBL] [Abstract][Full Text] [Related]
32. Normocalcemic primary hyperparathyroidism: an update.
Salcuni AS; Battista C; Pugliese F; Columbu C; Guarnieri V; Carnevale V; Scillitani A
Minerva Endocrinol (Torino); 2021 Sep; 46(3):262-271. PubMed ID: 33103871
[TBL] [Abstract][Full Text] [Related]
33. Measured free 25-hydroxyvitamin D in healthy children and relationship to total 25-hydroxyvitamin D, calculated free 25-hydroxyvitamin D and vitamin D binding protein.
Lopez-Molina M; Santillan C; Murillo M; Valls A; Bosch L; Bel J; Granada ML
Clin Biochem; 2018 Nov; 61():23-27. PubMed ID: 30130523
[TBL] [Abstract][Full Text] [Related]
34. Plasma 25-hydroxyvitamin D and not 1,25-dihydroxyvitamin D is associated with parathyroid adenoma secretion in primary hyperparathyroidism: a cross-sectional study.
Moosgaard B; Vestergaard P; Heickendorff L; Melsen F; Christiansen P; Mosekilde L
Eur J Endocrinol; 2006 Aug; 155(2):237-44. PubMed ID: 16868136
[TBL] [Abstract][Full Text] [Related]
35. Parathyroid hormone reference ranges in healthy individuals classified by vitamin D status.
Yalla N; Bobba G; Guo G; Stankiewicz A; Ostlund R
J Endocrinol Invest; 2019 Nov; 42(11):1353-1360. PubMed ID: 31273631
[TBL] [Abstract][Full Text] [Related]
36. Plasma 25-hydroxyvitamin D, 1,25-dihydroxyvitamin D, and parathyroid hormone in familial hypocalciuric hypercalcemia and primary hyperparathyroidism.
Christensen SE; Nissen PH; Vestergaard P; Heickendorff L; Rejnmark L; Brixen K; Mosekilde L
Eur J Endocrinol; 2008 Dec; 159(6):719-27. PubMed ID: 18787045
[TBL] [Abstract][Full Text] [Related]
37. The Eucalcemic Patient With Elevated Parathyroid Hormone Levels.
Shaker JL; Wermers RA
J Endocr Soc; 2023 Feb; 7(4):bvad013. PubMed ID: 36793479
[TBL] [Abstract][Full Text] [Related]
38. Urinary calcium excretion in primary hyperparathyroidism: relationship to 25-hydroxyvitamin d status.
Bussey AD; Bruder JM
Endocr Pract; 2005; 11(1):37-42. PubMed ID: 16033734
[TBL] [Abstract][Full Text] [Related]
39. Vitamin D deficiency in veterans with chronic spinal cord injury.
Bauman WA; Zhong YG; Schwartz E
Metabolism; 1995 Dec; 44(12):1612-6. PubMed ID: 8786732
[TBL] [Abstract][Full Text] [Related]
40. Efficacy of High vs. Conventional Ergocalciferol Dose for Increasing 25-Hydroxyvitamin D and Suppressing Parathyroid Hormone Levels in Stage III-IV CKD with Vitamin D Deficiency/Insufficiency: A Randomized Controlled Trial.
Thimachai P; Supasyndh O; Chaiprasert A; Satirapoj B
J Med Assoc Thai; 2015 Jul; 98(7):643-8. PubMed ID: 26267985
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
